Highest-scoring questions on the site.
Conditions: SUSTAIN-6 · dizziness · 60 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Conditions: aspartimide formation · liraglutide · 30 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
The case in front of me: survodutide · SURMOUNT-4. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
Conditions: nausea · oral semaglutide · TRIUMPH-3. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Setup, so nobody has to ask: Janoshik · Medutest · ecnoglutide. Both of these get recommended confidently by different people, which suggests neither is obviously…
Concretely: SOUL · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change…
The case in front of me: 99.1% · VendorInvestigate · 99.4%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want…
Concretely: 96.4% · VendorInvestigate · 99.4% · Janoshik. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
Concretely: ecnoglutide · four weeks. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
What I have: SGN · Shanghai ERP Biotechnology. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Setup, so nobody has to ask: STEP 3 · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I…
Details up front: a GLP-1 receptor agonist · 4 mg/mL. I would like to understand the steps well enough to explain them to someone else. I have access to a…
The case in front of me: an escrowed payment · Japan. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the…
What I am working with: a 30G needle · a GLP-1 receptor agonist · 6.67 mg/mL. Both of these get recommended confidently by different people, which suggests neither is…
The case in front of me: survodutide · 3.33 mg/mL · ten weeks. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone…
Setup, so nobody has to ask: 20 mg · a GLP-1 receptor agonist. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
Concretely: PIONEER-4 · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
The case in front of me: semaglutide · 3.33 mg/mL. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…
What I am working with: retatrutide · a C18 column · retatrutide. Both of these get recommended confidently by different people, which suggests neither is obviously…
The particulars: oral semaglutide · 30 °C. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned…
Concretely: ESSENCE · tirzepatide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which…
What I am working with: retatrutide · two weeks · 37 °C. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
The case in front of me: semaglutide · twelve weeks · 30 °C. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…
The case in front of me: 10 mg · oral semaglutide. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…